Estring

DRUG2 trials

Sponsors

University of California, San Francisco, Polly A. Niravath, MD

Conditions

Breast CancerEstrogen Receptor Positive Breast CancerSexual Dysfunction, Physiological

Phase 2

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

CompletedNCT00698035

University of California, San FranciscoSexual Dysfunction, Physiological

Start: 2007-03-31End: 2012-12-31Updated: 2014-06-02

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Active, not recruitingNCT01984138

Polly A. Niravath, MDBreast Cancer, Estrogen Receptor Positive Breast Cancer

Start: 2013-09-01End: 2026-06-01Updated: 2026-01-28

Related Papers

Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer

JAMA Oncology2016-11-10146 citations